Pleiotropic Effects of ARB in Diabetes Mellitus

Author(s): Shu-ichi Saitoh, Yasuchika Takeishi

Journal Name: Current Vascular Pharmacology

Volume 9 , Issue 2 , 2011

Become EABM
Become Reviewer
Call for Editor


Evidence accumulated to date indicates that inhibition of the renin-angiotensin system with angiotensin receptor blockers (ARB) may prevent new-onset of diabetes. ARB is also used for the prevention of occurrence and progression of complications in diabetes and diabetic nephropathy. From the results of recent large-scale clinical studies, ARB is considered as a first choice drug in hypertensive patients with diabetes. In this review article, we focus on the effects of ARB on progression and prevention against diabetes as a metabolic-improving agent.

Keywords: Metabolism, prevention, nephropathy, retinopathy

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Published on: 01 March, 2012
Page: [136 - 144]
Pages: 9
DOI: 10.2174/157016111794519363
Price: $65

Article Metrics

PDF: 8